Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events

Published:2021-01-30 Issue:2 Volume:41 Page:1021-1026
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

TAKAI RYO,FUNAKOSHI YOHEI,SUTO HIROTAKA,NAGATANI YOSHIAKI,IMAMURA YOSHINORI,TOYODA MASANORI,YAKUSHIJIN KIMIKAZU,KIYOTA NAOMI,HARADA KEN-ICHI,YAMASHITA KIMIHIRO,KAKEJI YOSHIHIRO,MINAMI HIRONOBU

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity;Frontiers in Cardiovascular Medicine;2024-06-10

2. A Case of Esophageal Cancer With Markedly Elevated Soluble Interleukin-2 Receptor: A Potential of Soluble Interleukin-2 Receptor as a Biomarker;Cureus;2024-04-02

3. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever;Scientific Reports;2023-11-01

4. Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies;Molecular Cancer;2023-07-29

5. Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma;International Journal of Hematology;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP